'Hopefully, if it can’t help me it can help others,' says local man in clinical trial for FDA-approved Alzheimer's drug

The FDA on Monday approved an experimental drug that aims to slow the progression of Alzheimer's disease after a key FDA panel late last year said that questions remain about its effectiveness. We spoke to a man who was involved in one clinical trial for the drug at Cleveland Clinic.